Prevalence Estimates for Latent Neurodegenerative Disease

Por Montine, Thomas J.
Publicado em 2010

PD biomarkers—use of α-synuclein reaches new levels

Por Montine, Thomas J.
Publicado em 2011

Biomarkers of oxidative damage and inflammation in Alzheimer’s disease

Por Galasko, Douglas, Montine, Thomas J
Publicado em 2010

Anatomic and Clinical Pathology of Cognitive Impairment and Dementia

Por Montine, Kathleen S., Montine, Thomas J.
Publicado em 2013

Precision medicine: Clarity for the clinical and biological complexity of Alzheimer’s and Parkinson’s diseases

Por Montine, Thomas J., Montine, Kathleen S.
Publicado no J Exp Med (2015)

Fatty Acid Oxidation in the Pathogenesis of Alzheimer’s Disease

Por Montine, Thomas J., Morrow, Jason D.
Publicado em 2005

Late-Life Dementias: Does This Unyielding Global Challenge Require a Broader View?

Por Montine, Thomas J., Larson, Eric B.
Publicado em 2009

The Genetics and Neuropathology of Alzheimer’s Disease

Por Schellenberg, Gerard D., Montine, Thomas J.
Publicado em 2012

Prostanoid signaling: dual role for prostaglandin E(2) in neurotoxicity

Por Milatovic, Dejan, Montine, Thomas J., Aschner, Michael
Publicado em 2011

Measurement of Isoprostanes as Markers of Oxidative Stress

Por Milatovic, Dejan, Montine, Thomas J., Aschner, Michael
Publicado em 2011

Apolipoprotein E-specific innate immune response in astrocytes from targeted replacement mice

Por Maezawa, Izumi, Maeda, Nobuyo, Montine, Thomas J, Montine, Kathleen S
Publicado em 2006

Microglia Lacking E Prostanoid Receptor Subtype 2 Have Enhanced Aβ Phagocytosis yet Lack Aβ-Activated Neurotoxicity

Por Shie, Feng-Shiun, Breyer, Richard M., Montine, Thomas J.
Publicado em 2005

Mitochondrial therapeutics in Alzheimer's disease and Parkinson's disease

Por Hoekstra, Jake G, Montine, Kathleen S, Zhang, Jing, Montine, Thomas J
Publicado em 2011

APOE genotype-dependent modulation of astrocyte chemokine CCL3 production

Por Cudaback, Eiron, Yang, Yue, Montine, Thomas J., Keene, C. Dirk
Publicado no Glia (2014)

Different mechanisms of apolipoprotein E isoform–dependent modulation of prostaglandin E(2) production and triggering receptor expressed on myeloid cells 2 (TREM2) expression after...

Por Li, Xianwu, Montine, Kathleen S., Keene, C. Dirk, Montine, Thomas J.
Publicado no FASEB J (2015)

Type 2 Diabetes, Cognition, and Dementia in Older Adults: Toward a Precision Health Approach

Por Cholerton, Brenna, Baker, Laura D., Montine, Thomas J., Craft, Suzanne
Publicado no Diabetes Spectr (2016)

Modulation of Microglial Innate Immunity in Alzheimer’s Disease by Activation of Peroxisome Proliferator-activated Receptor Gamma

Por Shie, Feng-Shiun, Nivison, Mary, Hsu, Pei-Chien, Montine, Thomas J.
Publicado em 2009

Alzheimer’s Disease Sequencing Project Discovery and Replication criteria for cases and controls: data from a community-based prospective cohort study with autopsy follow-up

Por Crane, Paul K., Foroud, Tatiana, Montine, Thomas J., Larson, Eric B.
Publicado no Alzheimers Dement (2017)

Proteomics of Human Neurodegenerative Diseases

Por Zhang, Jing, Keene, C. Dirk, Pan, Catherine, Montine, Kathleen S., Montine, Thomas J.
Publicado em 2008

DOCK2 Is a Microglial Specific Regulator of Central Nervous System Innate Immunity Found in Normal and Alzheimer’s Disease Brain

Por Cimino, Patrick J., Sokal, Izabela, Leverenz, James, Fukui, Yoshinori, Montine, Thomas J.
Publicado em 2009